Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
Platinum based adjuvant chemotherapy is generally recommended for ovarian cancer to improve the survival rate. Intravenous route is commonly used, easily administered and less associated complications. However, intraperitoneal route is gaining its popularity as a single procedure or adjunctive to th...
Main Authors: | Shafiee MN, Omar MH, Suraya A, Hatta M |
---|---|
Format: | Article |
Language: | English |
Published: |
Department of Surgery, UKM Medical Centre
2013
|
Online Access: | http://journalarticle.ukm.my/6672/ http://journalarticle.ukm.my/6672/ http://journalarticle.ukm.my/6672/1/09-MS1079_%2828-31%29.pdf |
Similar Items
-
‘Emergency chemotherapy’ for bleeding cervical cancer: case series
by: Shafiee, MN, et al.
Published: (2012) -
Fuels and refractories
by: GILCHRIST
Published: (1966) -
Pharmacokinetic and pharmacodynamic features of nanoemulsion following oral, intravenous, topical and nasal route
by: Chowdhury, Hira, et al.
Published: (2017) -
Applications of calixarenes in cancer chemotherapy: facts and perspectives
by: Ali, Yousaf, et al.
Published: (2015) -
Ovarian cancer? Wait for results
by: Azizan, Azha Syahril, et al.
Published: (2010)